* We have studied as a model system an archetypical representative of the ubiquitous major facilitator superfamily, the Escherichia coli lactose permease (LacY). By using a combination of established indicators of cross-β structure and morphology, including the amyloid diagnostic dye thioflavin-T, circular dichroism spectroscopy, Fourier transform infrared spectroscopy, X-ray fiber diffraction, and transmission electron microscopy, we have shown that LacY can form amyloid-like fibrils under destabilizing conditions. These results indicate that transmembrane α-helical proteins, similarly to cytosolic proteins, have the ability to adopt this generic state.(Stroobants, Kumita et al 2017 Biochemistry)
This work was presented at ‘STUNNING Structure and function in signaling’, on November 18th 2016, in Brussels, Belgium; ‘Marie Curie Alumni Association (MCAA) conference and general assembly’, on March 24th-25th 2017, in Salamanca, Spain; 9th Building Bridges in Medical Sciences (BBMS) conference, on March 10th 2017, in Cambridge, UK; CSH meeting on Protein Homeostasis In Health & Disease, on April 18th-22nd 2016, in Cold Spring Harbor, US
* We have studied three S. cerevisiae model systems of challenged mitochondrial import; either by overexpression of the import substrates of interest (selected mitochondrial membrane proteins), by chemical disruption of the mitochondrial potential, or temperature sensitive import mutations. In these models, we identified a sarkosyl-resistant aggregate fraction containing presequence-proteins of the oxidative phosphorylation. We found that inhibition of the proteasome leads to an increase in the aggregate load, and we observed a specific aggregate-associated chaperone response in the cytosol.(manuscript in preparation)
This work was presented at Science meets Parliaments, on 28th November 2017, at Brussels, Belgium; Proteostasis in Health and Disease Symposium, on 20th-22nd November 2017, in Wollongong, Australia; 67th Lindau Nobel Laureates Meeting, on 25th-30th June 2017, in Lindau, Germany; EMBO Conference on Protein Quality Control: Success and failure in health and disease, on May 14th-19th 2017, in Girona, Spain